Product Information
PITAVASTATIN 4 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $1.2721 per EA under NDC 72603048001. Its NADAC has been published 61 times since Apr 30, 2025.
The High Outlier badge above means this manufacturer's average price in the pitavastatin calcium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
4.18 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603048001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PITAVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205977On Market Since
12/1/2024
Pharmacological Classes
Price Statistics
The NADAC for PITAVASTATIN 4 MG TABLET has been published 61 times since Apr 30, 2025, and over the history we have for it it has declined 22.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2721 per EA |
|---|---|
| All-time high | $1.6472 (May 14, 2025) |
| All-time low | $1.2721 (Jun 17, 2026) |
| 52-week high | $1.5488 |
| 52-week low | $1.2721 |
| Median price | $1.4690 |
| Average price | $1.4653 |
| Largest weekly change | -6.7% (May 21, 2025) |
| Weeks tracked | 61 |
| Tracking since | Apr 30, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PITAVASTATIN 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 4 MG TABLET, manufactured by NorthStar Rx LLC, is $1.2721 per EA (NDC 72603048001), effective Jun 24, 2026.
How has the price of PITAVASTATIN 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PITAVASTATIN 4 MG TABLET has declined 22.8%. It has been tracked across 61 weekly CMS publications since Apr 30, 2025.
What are the highest and lowest recorded NADAC prices for PITAVASTATIN 4 MG TABLET?
Since Apr 30, 2025, the NADAC for PITAVASTATIN 4 MG TABLET has ranged from a low of $1.2721 (Jun 17, 2026) to a high of $1.6472 (May 14, 2025), with a median of $1.4690 per EA.
Are there cheaper alternatives to PITAVASTATIN 4 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as PITAVASTATIN 4 MG TABLET, but none are currently priced below it.
Who manufactures PITAVASTATIN 4 MG TABLET?
PITAVASTATIN 4 MG TABLET (NDC 72603048001) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification